EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Intravenous Opioid Medication with Piritramide Reduces the Risk of Pneumothorax During CT-Guided Percutaneous Core Biopsy of the Lung

Andrea Goetz, Florian Poschenrieder, Frederike Georgine Steer, Florian Zeman, Tobias J Lange, Sylvia Thurn, Barbara Greiner, Christian Stroszczynski, Wibke Uller, Okka Hamer, Simone Hammer

CardioVascular and Interventional Radiology · 2024-05 · 47 (5) · 621-631

DOI: 10.1007/s00270-024-03717-w ↗

Kurz gefasst

Fachartikel in der Zeitschrift CardioVascular and Interventional Radiology, online erschienen am 19.04.2024. Verfasst von Andrea Goetz und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology, University Hospital Regensburg, Franz-Josef-Strauss-Allee 11, 93053, Regensburg, Germany. andrea3.goetz@ukr.de. Hauptthemen laut MEDLINE: Pneumothorax, Tomography, X-Ray Computed, Analgesics, Opioid, Radiography, Interventional. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Universitätsklinikum Regensburg.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

CT-guided percutaneous core biopsy of the lung is usually performed under local anesthesia, but can also be conducted under additional systemic opioid medication. The purpose of this retrospective study was to assess the effect of intravenous piritramide application on the pneumothorax rate and to identify risk factors for post-biopsy pneumothorax. Materials and Methods One hundred and seventy-one core biopsies of the lung were included in this retrospective single center study. The incidence of pneumothorax and chest tube placement was evaluated. Patient-, procedure- and target-related variables were analyzed by univariate and multivariable logistic regression analysis.

Results

The overall incidence of pneumothorax was 39.2% (67/171). The pneumothorax rate was 31.5% (29/92) in patients who received intravenous piritramide and 48.1% (38/79) in patients who did not receive piritramide. In multivariable logistic regression analysis periinterventional piritramide application proved to be the only independent factor to reduce the risk of pneumothorax (odds ratio 0.46, 95%-confidence interval 0.24, 0.88; p = 0.018). Two or more pleura passages (odds ratio 3.38, 95%-confidence interval: 1.15, 9.87; p = 0.026) and prone position of the patient (odds ratio 2.27, 95%-confidence interval: 1.04, 4.94; p = 0.039) were independent risk factors for a higher pneumothorax rate.

Conclusion

Procedural opioid medication with piritramide proved to be a previously undisclosed factor decreasing the risk of pneumothorax associated with CT-guided percutaneous core biopsy of the lung. Level of Evidence 4 small study cohort. Graphic Abstract

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PneumothoraxTomography, X-Ray ComputedAnalgesics, OpioidRadiography, InterventionalImage-Guided BiopsyLungPirinitramideHumansFemaleMaleRetrospective StudiesMiddle AgedAgedRisk FactorsAdultIncidence

Stichwörter der Autor:innen

AnalgesicsBiopsyComputed tomographyOpioidPiritramidePneumothoraxRisk factors

Substanzen

Analgesics, OpioidPirinitramide

Autor:innen und Institutionen

  • Department of Radiology, University Hospital Regensburg, Franz-Josef-Strauss-Allee 11, 93053, Regensburg, Germany. andrea3.goetz@ukr.de.
  • Department of Radiology, University Hospital Regensburg, Franz-Josef-Strauss-Allee 11, 93053, Regensburg, Germany.
  • Center for Clinical Trials, University Hospital Regensburg, Franz-Josef-Strauss-Allee 11, 93053, Regensburg, Germany.
  • Department of Internal Medicine II, University Hospital Regensburg, Franz-Josef-Strauss-Allee 11, 93053, Regensburg, Germany.
  • Department of Diagnostic and Interventional Radiology, Faculty of Medicine, Medical Center University of Freiburg, Hugstetter Straße 55, 79106, Freiburg, Germany.

Förderung

  • Universitätsklinikum Regensburg

Zitieren

APA

Goetz, A., Poschenrieder, F., Steer, F. G., Zeman, F., Lange, T. J., Thurn, S., Greiner, B., Stroszczynski, C., Uller, W., Hamer, O., & Hammer, S. (2024). Intravenous Opioid Medication with Piritramide Reduces the Risk of Pneumothorax During CT-Guided Percutaneous Core Biopsy of the Lung. CardioVascular and Interventional Radiology, 47(5), 621-631. https://doi.org/10.1007/s00270-024-03717-w

Vancouver

Goetz A, Poschenrieder F, Steer FG, Zeman F, Lange TJ, Thurn S, et al. Intravenous Opioid Medication with Piritramide Reduces the Risk of Pneumothorax During CT-Guided Percutaneous Core Biopsy of the Lung. CardioVascular and Interventional Radiology. 2024;47(5):621-631. doi:10.1007/s00270-024-03717-w

BibTeX
@article{Goetz2024,
  author = {Goetz, Andrea and Poschenrieder, Florian and Steer, Frederike Georgine and Zeman, Florian and Lange, Tobias J and Thurn, Sylvia and Greiner, Barbara and Stroszczynski, Christian and Uller, Wibke and Hamer, Okka and Hammer, Simone},
  title = {Intravenous Opioid Medication with Piritramide Reduces the Risk of Pneumothorax During CT-Guided Percutaneous Core Biopsy of the Lung},
  journal = {CardioVascular and Interventional Radiology},
  year = {2024},
  volume = {47},
  number = {5},
  pages = {621--631},
  doi = {10.1007/s00270-024-03717-w}
}
Kostenlos starten →